Pathogenesis of Graves' disease: Molecular analysis of anti-thyrotropin receptor antibodies

Endocrine Journal

Volumn 44, Issue 5, 1997, Pages 633-646

  Akamizu, Takashi ^a   Mori, Toru ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN RECEPTOR ANTIBODY;

ENVIRONMENTAL FACTOR; GRAVES DISEASE; HEREDITY; HUMAN; PATHOGENESIS; REVIEW; SEQUENCE HOMOLOGY;

EID: 0031449490     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.44.633     Document Type: Review

References (64)

1. Davies TF (1996) Graves' disease. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid. 7th ed, Lippencott, Philadelphia: 525-536.
2. Burman KD, Baker Jr JR (1985) Immune mechanisms in Graves' disease. Endocr Rev 6: 183-2323.
3. Rees-Smith B, McLachlan SM, Furmaniak J (1988) Autoantibodies to the thyrotropin receptor. Endocr Rev 9: 106-121.
4. Mori T, Akamizu T, Kosugi S, Sugawa H, Inoue D, Okuda J, Ueda Y. (1994) Recent progress in TSH receptor studies with a new concept of "autoimmune TSH receptor disease". Endocr J 41: 1-11.
5. Akamizu T, Kohn LD, Mori T (1995) Molecular studies on thyrotropin (TSH) receptor and anti-TSH receptor antibodies. Endocr J 42: 617-627.
6. Volpé R (1991) Graves' disease. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid. 7th ed, Lippencott, Philadelphia: 648-657.
7. Skillern PG (1972) Genetics of Graves' disease. Mayo Clin Proc 47: 848-849.
8. Mckenzie JM, Zakarija M (1989) Hyperthyroidism. In: DeGroot LJ, Besser GM, Cahill GF, Marshall JC, Nelson DH, Odell WD, Potts JT, Rubenstein AH, Steinberger E (eds) Endocrinology. Saunders, Philadelphia: 646-682.
9. Uno H, Sasazuki T, Tamai H, Matsumoto H (1981) Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature 292: 768-770.
10. Cuddihy RM, Dutton CM, Bahn RS (1995) A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid 5: 89-95.
11. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ (1995) CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 80: 41-45.
12. Blakemore AIF, Watson PF, Weetman AP, Duff GW (1995) Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metabol 80: 111-115.
13. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PPB, Cheah JS, Thomson G (1989) Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves Disease. Am J Hum Genet 45: 541-546.
14. Farid, NR, Sampson L, Noel EP, Barnard JM, Mandeville R, Larsen B, Marshall WH (1979) A study of human leukocyte D locus related antigens in Graves' disease. J Clin Invest 63: 108-113.
15. Allannic H, Fauchet R, Lorcy Y, Heim J, Gueguen M, Leguerrier A-M, Genetet B (1980) HLA and Graves' disease: An association with HLA-DRw3. J Clin Endocrinol Metab 51: 863-867.
16. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF (1992) Genetics of autoimmune thyroid disease: Lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 74: 496-503.
17. Wilkin G (1990) The primary lesion theory of autoimmunity: A speculative hypothesis. Autoimmunity 7: 225-235.
18. Wick G, KrömerG, Neu N, Fässler R, Ziemiecki A, Müller RG, Ginzel M, Béládi I, Kühr T, Hála K (1987) The multi-factorial pathogenesis of autoimmune disease. Immunol Lett 16: 249-258.
19. Akamizu T, Sale MM, Yokota T, Nakao K, Mori T, Iwasaki H, Yoshimura H, Ito K, Rich SS, Jennings-Gee JE, Bowden DW (1997) Isolation of a microsatellite marker for the thyrotropin receptor gene and its association with autoimmune thyroid diseases in a Japanese population. Thyroid (suppl) (In press).
20. Sale MM, Akamizu T, Howard TD, Yokota T, Nakao K, Mori T, Iwasaki H, Rich SS, Jennings-Gee JE, Yamada M, Bowden DW (1997) Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population. Proc Assoc Amer Physicians 109: 453-461.
21. Libert, F, Passage E, Lefort A, Vassart G, Mattei M-G (1990) Localization of human thyrotropin receptor gene to chromosome region 14q31 by in situ hybridization. Cytogenet Cell Genet 54: 82-83.
22. Rousseau-Merck, MF, Misrahi M, Loosfelt H, Atger M, Milgrom E, Berger R (1990) Assignment of the human thyroid stimulating hormone receptor (TSHR) gene to chromosome 14q31. Genomics 8: 233-236.
23. Akamizu T, Ikuyama S, Saji M, Kosugi S, Kozak C, McBride WO, Kohn LD (1990) Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: Expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. Proc Natl Acad Sci USA 87: 5677-5681.
24. Heldin N-E, Gustavsson B, Westermark K, Westermark B (1991) A somatic point mutation in a putative ligand binding domain of the TSH receptor in a patient with autoimmune hyperthyroidism. J Clin Endocrinol Metab 73: 1374-1376.
25. Bohr URM, Behr M, Loos U (1993) A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulins. Biochim Biophys Acta 1216: 504-505.
26. Bahn RS, Dutton CM, Heufelder AE, Sarkar G (1994) A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 78: 256-260.
27. Nisticò L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Martinez Larrad MT, Serrano Rios M, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Belgian Diabetes Registry, Tosi R, Pozzilli P, Todd JA (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Molec Genet 5: 1075-1080.
28. Harper K, Balzano C, Rouvier E, Mattéi M-G, Luciani M-F, Golstein P (1991) CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 147: 1037-1044.
29. Buonavista N, Balzano C, Pontarotti P, Le Paslier D, Golstein P (1992) Molecular linkage of the human CTLA4 and CD28 Ig-superfamily genes in yeast artificial chromosomes. Genomics 13: 856-861.
30. Donner H, Rau H, Walfish PG, Braun J, Siegmund T, Finke R, Herwig J, Usadel KH, Badenhoop K (1997) CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 82: 143-146.
31. Benvenga S (1996) Benzodiazepine and remission of Graves' disease. Thyroid 6: 659-660.
32. Dai G, Levy O, Carrasco N (1996) Cloning and characterization of the thyroid iodide transporter. Nature 379: 458-460.
33. Sinha AA, Lopez T, McDevitt (1990) Autoimmune diseases: The failure of self tolerance. Science 248: 1380-1388.
34. Nossai GJV (1994) Negative selection of lymphocytes. Cell 76: 229-239.
35. Nagayama Y, Rapoport B (1992) The thyrotropin receptor 25 years after its discovery: New insight after its molecular cloning. Mol Endocrinol 6: 145-156.
36. Kohn LD, Kosugi S, Ban T, Saji M, Ikuyama S, Giuliani C, Hidaka A, Shimura H, Akamizu T, Tahara K, Moriarty J, Prabhakar BS, Singer DS (1992) Molecular basis for the autoactivity against thyroid stimulation hormone receptor. Intern Rev Immunol 9: 135-165.
37. Shin EK, Akamizu T, Matsuda F, Sugawa H, Fujikura J, Mori T, Honjo T (1994) Variable-regions of immunoglobulin heavy-chain genes encoding antithyrotropin (TSH) receptor antibodies of patients with Graves' disease. J Immunol 152: 1485-1492.
38. Okuda J, Akamizu T, Sugawa H, Matsuda F, Li H, Mori T (1994) Preparation and characterization of monoclonal antithyrotropin receptor antibodies obtained from peripheral lymphocytes of hypothyroid patients with primary myxedema. J Clin Endocrinol Metab 79: 1600-1604.
39. Li H, Akamizu T, Okuda J, Sugawa H, Matsuda F, Tsubata T, Mori T (1995) Isolation of Epstein-Barr virus-transformed lymphocytes producing IgG class monoclonal antibodies using a Magnetic Cell separator (MACS): Preparation of thyroid-stimulating IgG antibodies from patients with Graves' disease. Biochem Biophy Res Commun 207: 985-993.
40. Akamizu T, Matsuda F, Okuda J, Li H, Kanda H, Watanabe T, Honjo T, Mori T (1996) Molecular analysis of stimulatory antithyrotropin receptor antibodies (TSAbs) involved in Graves' disease: Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs. J Immunol 157: 3148-3152.
41. Okuda J, Akamizu T, Matsuda F (1995) Variable regions of immunoglobulin genes encoding "blocking type" antithyrotropin recepter antibodies of patients with primary myxedema. Thyroid 5 (suppl 1): S-210 (abst).
42. Valente WA, Vitti P, Yavin Z, Yavin E, Rotella CM, Grollman EF, Toccafondi RS, Kohn LD (1982) Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lymphocytes of patients with Graves' disease. Proc Natl Acad Sci USA 79: 6680-6684.
43. Yoshida T, Ichikawa Y, Ito K, Homma M (1988) Monoclonal antibodies to the thyrotropin receptor bind to a 56-KDa subunit of the thyrotropin receptor and show heterogeneous bioactivities. J Biol Chem 263: 16341-16347.
44. Baker JR, Saunders NR, Kaulferoch W, Burman KD (1988) Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen. J Immunol 140: 2593-2599.
45. Kohn LD, Valente WA, Lacetti P, Cohen JL, Aloj SM, Grollman EF (1983) Multicomponent structure of the thyrotropin receptor: Relationship to Graves' disease. Life Sci 32: 15-30.
46. Takeda K, Takamatsu J, Kasagi K, Sakane S, Ikegami Y, Isotani H, Majima T, Kitaoka H, Iida Y, Ikekubo K, Konishi J, Mozai T (1988) Development of hyperthyroidism following primary hypothyroidism: A case report with changes in thyroid-related antibodies. Clin Endocrinol 28: 341-344.
47. Miyauchi A, Amino N, Tamaki H, Kuma K (1988) Coexistence of thyroid-stimulating and thyroid-blocking antibodies in a patient with Graves' disease who had transient hypothyroidism. Am J Med 85: 418-420.
48. Tamai H, Kasagi K, Takaichi Y, Takamatsu J, Komaki G, Matsubayashi S, Konishi J, Kuma K, Kumagai LF, Nagataki S (1989) Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: Clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab 69: 49-53.
49. Morgenthaler NG, Kim MR, Tremble J, Huang GC, Richter W, Gupta M, Scherbaum WA, McGregor AM, Banga JP (1989) Human IgG autoantibodies to the thyrotropin receptor from Epstein-Bar virus transformed B lymphocytes: Characterization by immunoprecipitation with recombinant antigen, and biological activity. J Clin Endocrinol Metab 81: 3155-3161.
50. McLachlan SM, Rapoport B (1996) Editorial: Monoclonal, human autoantibodies to the TSH receptor - The holy grail and why are we looking for it? J Clin Endocrinol Metab 81: 3152-3154.
51. Weetman AP, Yateman ME, Ealey PA, Black C, Reimer CB, Williams RC, Shine B, Marshal NJ (1990) Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 86: 723-727.
52. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-793.
53. Finkelman FD (1995) Relationships among antigen presentation, cytokines, immune deviation, and autoimmune disease. J Exp Med 182: 279-282.
54. Ajjan RA, Watson PF, Weetman AP (1997) Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 82: 666-669.
55. Lombarde G, Arnold K, Uren J, Marelli-Berg F, Hargreaves R, Imami N, Weetman A, Lechler R (1997) Antigen presentation by interferon-γ-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cell. Eur J Immunol 27: 62-71.
56. Shimojo N, Kohno Y, Yamaguchi KI, Kikuoka SI, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K (1996) Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and class II molecule. Proc Natl Acad Sci USA 93: 11074-11079.
57. Okamoto M, Murakami M, Shimizu A, Ozaki S, Tsubata T, Kumagai S, Honjo T (1992) A transgenic model of autoimmune hemolytic anemia.J Exp Med 175: 71-79.
58. Murakami M, Tsubata T, Okamoto M, Shimizu A, Kumagai S, Imura H, Honjo T (1992) Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357: 77-80.
59. Wall J (1995) Extrathyroidal manifestations of Graves' disease. J Clin Endocrinol Metab 80: 3427-3429.
60. Paschke R, Vassart G, Ludgate M (1995) Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol 42: 565-569.
61. Davies TF (1994) The thyrotropin receptors spread themselves around. J Clin Endocrinol Metab 79: 31232-31233.
62. Koshiyama H, Sellitti DF, Akamizu T, Doi SQ, Takeuchi Y, Inoue D, Sakaguchi H, Takemura G, Sato Y, Takatsu Y, Nakao K (1996) Cardiomyopathy associated with Graves' disease. Clinical Endocrinol 45: 111-116.
63. Honjo T, Matsuda F (1995) Immunoglobulin heavy chain loci of mouse and human. In: Honjo T, Alt FW (eds) Immunoglobulin Genes. 2nd ed, Academic Press, London: 145-171.
64. Zahau HG (1995) The human immunoglobulin k genes. In: Honjo T, Alt FW (eds) Immunoglobulin Genes. 2nd ed, Academic Press, London: 173-191.